SP/RNS7 Nov 2018 12:35
Finally calmed down and accepted my current paper loss, hopefully its nothing but a short term dip...
All IMO and do your own research, not to be taken as investment advice
Negatives:-
- Obvious Discount and Dilution
- Why did they not use the Bank Facility of 660K? (*Corrected - was down to the territory, so they couldn't use it)
- Concerns that every time a contract comes in we have to raise cash
- Flippers, going to be a lot harder to reach 3p+ now
Positives
- SAS license included in price, so I estimate some ofthe 1.1m revenue will be of a decent margin
- As mentioned above, up front payment before delivery expected before Y/E
- Helios advanced and new market, was a little concerned Helios had fell behind but not the case
Major Positives
- 2.5m potential in 2019, this would be a game changer to the bottom line
Summary:-
Forced hand in a bad market, obviously they would have liked to have raised at a higher price but the market sent us down here (2.3-2.4)
Would have had to turn down the deal if no placing acquired, long term this deal is a huge positive especially if 2.5m is realized, the margin on the 1.1m could even be higher than the 400K raised (as SAS included) so just like injecting cash into the company to some degree...
Territory reasons on why they couldn't do the 660K bank facility so hopefully all of that is still in tact, and the next RNS may be able to use it = no placing and excellent revenue and bottom line for future updates
I'm not happy and certainly not trying to ramp this share, its been a rollercoaster 12 months, and hasn't been exactly great but the price is what it is and I have to treat it based on where I think it is going to be in 12 months from here
IMO DYOR not investment advice